•
Jun 30, 2024

UnitedHealth Q2 2024 Earnings Report

UnitedHealth Group's Q2 2024 performance reflected growth in revenues and earnings, but was impacted by cyberattack related costs and classification of South American operations as held for sale.

Key Takeaways

UnitedHealth Group reported Q2 2024 results with revenues of $98.9 billion, a $6 billion year-over-year increase led by Optum. Reported earnings were $4.54 per share, while adjusted earnings were $6.80 per share, including $0.28 in business disruption impacts. The company updated its full year 2024 net earnings outlook to $15.95 to $16.40 per share.

Revenues grew nearly $6 billion year-over-year to $98.9 billion, led by Optum.

Consumers served by UnitedHealthcare's commercial domestic offerings grew by 2.3 million year-to-date.

Cash flows from operations were $6.7 billion, 1.5 times net income.

Adjusted earnings of $6.80 per share include $0.28 in business disruption impacts and exclude South American and direct response costs.

Total Revenue
$98.9B
Previous year: $92.9B
+6.4%
EPS
$6.8
Previous year: $6.14
+10.7%
Optum Health Consumers
104M
Gross Profit
$21.1B
Previous year: $21.8B
-3.3%
Cash and Equivalents
$26.3B
Previous year: $41.8B
-37.1%
Free Cash Flow
$5.89B
Previous year: $10.2B
-42.2%
Total Assets
$286B
Previous year: $280B
+2.1%

UnitedHealth

UnitedHealth

UnitedHealth Revenue by Segment

Forward Guidance

The company updated its full year 2024 net earnings outlook to $15.95 to $16.40 per share to reflect the classification to held for sale of its remaining South America operations and the estimated Change Healthcare cyberattack impacts. The company affirmed the adjusted net earnings outlook of $27.50 to $28.00 per share established at its November 2023 Investor Conference.

Revenue & Expenses

Visualization of income flow from segment revenue to net income